Broadcom isn’t just another chipmaker riding the semiconductor cycle, it’s a carefully assembled portfolio of some of the stickiest, most profitable businesses in tech.
At its core, Broadcom has mastered the art of acquisition, folding niche leaders into its empire, stripping out inefficiencies, and using the resulting free cash flow to fuel dividends,
» Read more about: The Giant at the Intersection of AI, Networking and Software »
Palantir Technologies (NYSE: PLTR), the data analytics powerhouse, has been one of Wall Street’s most explosive success stories. Since its direct listing in late 2020 at $10 a share, the stock has soared by almost 18-fold gain. Over that same stretch, the S&P 500 hasn’t even doubled.
That kind of outperformance doesn’t happen by accident.
» Read more about: Palantir’s Run Feels Unstoppable, But for How Long? »
United Parcel Service has long been one of the world’s most trusted shipping giants, a backbone of global commerce that seems almost untouchable. But in the past half decade, shareholders have felt more turbulence than smooth sailing. The stock is down 46%.
That’s a sobering reality for a company many once viewed as a safe,
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
If you gave up on Dutch Bros after its post-IPO slump, you might be kicking yourself right now. After going public in 2021 and fizzling out soon after, Dutch Bros has staged a remarkable comeback, rising nearly 90% over the past 2 years.
And this rebound isn’t just a flash in the pan.
» Read more about: 1 Signal That Dutch Bros Could Be a Monster Stock »
The smartest growth opportunity on the market right now might not be a flashy newcomer at all. Instead, it’s a powerhouse that’s already central to nearly every major tech advancement, TSMC.
While names like Nvidia and Apple steal headlines, TSMC is the company making their breakthroughs possible, and that makes it one of the most overlooked,
» Read more about: The Smartest Growth Stock Hiding in Plain Sight »
While the spotlight often shines brightest on Nvidia, another chipmaker has been clawing its way into the conversation and could soon be in a position to steal the show.
That company is Advanced Micro Devices (NASDAQ: AMD), and it’s gearing up to report second-quarter earnings early next month.
With the stock already up 34% this year,
» Read more about: AMD’s AI Advantage May Just Be Getting Started »
Chances are, you’ve never walked into a store and bought something with the ASML logo on it but almost every smartphone, tablet, or electric vehicle in your life probably wouldn’t exist without ASML’s technology humming away in the background.
This Dutch powerhouse doesn’t make chips, it makes the machines that make the chips.
» Read more about: Forget Nvidia, This Under-the-Radar Chip Stock Might Have More Upside »
SoFi’s rise over the past few years has been stunning. SoFi’s stock has surged over 3x over the past 3 years, handily outpacing blue-chip tech names, even those riding the artificial intelligence wave. But that eye-popping run might be both a blessing and a curse.
Investors are now wondering whether SoFi keep up the pace?
» Read more about: Is SoFi Still a Once-in-a-Generation Fintech Opportunity »
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »